Key Takeaways

• Kyndryl Holdings faces a class action lawsuit for allegedly violating the Securities Exchange Act of 1934.
• Investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, have until April 13, 2026, to apply as lead plaintiffs.
• The lawsuit claims Kyndryl misrepresented its financial statements and faced internal control issues, leading to a 55% stock price drop.

Overview of the Case Against Kyndryl

Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Kyndryl Holdings, Inc., focusing on potential violations of the Securities Exchange Act of 1934. This lawsuit, titled Brander v. Kyndryl Holdings, Inc., was filed in the Eastern District of New York and targets Kyndryl and its current and former executives. The class action period encompasses transactions made from August 7, 2024, to February 9, 2026, and investors have until April 13, 2026, to seek appointment as lead plaintiffs.

The allegations state that during the class period, Kyndryl made misleading statements regarding its financial health and internal controls. Specifically, the company is accused of issuing materially false financial statements and lacking adequate internal control systems. This situation became critical when, on February 9, 2026, Kyndryl announced it would submit a Notification of Late Filing for its Quarterly Report on Form 10-Q for the quarter ending December 31, 2025. Following this announcement, the company’s internal controls came under scrutiny, allegedly leading to the recognition of material weaknesses in its financial reporting.

Furthermore, the company acknowledged that the Audit Committee was reviewing cash management practices and corresponding disclosures, prompted by requests from the SEC’s Division of Enforcement. This investigation was expected to reveal significant failures in financial control, exacerbated by the abrupt departures of key company executives, including Chief Financial Officer David Wyshner and General Counsel Edward Sebold, which compounded investor concerns.

The fallout from these revelations led to a significant loss in Kyndryl’s stock value, with shares plummeting by 55%. The plaintiffs in the class action intend to hold Kyndryl accountable for these sharp losses and are looking for compensation for their financial injuries.

The Private Securities Litigation Reform Act of 1995 allows any investor who acquired Kyndryl’s publicly traded securities during the specified class period to apply for lead plaintiff status. This designation is typically awarded to the investor with the most substantial financial interest in the case and who can adequately represent the interests of the class. The lead plaintiff will manage the class action process and can select legal representation of their choice. Importantly, participating as a lead plaintiff does not affect an investor’s ability to recover damages.

Robbins Geller, a prominent law firm in securities fraud and shareholder rights litigation, has a strong track record of successful recoveries, totaling over $8.4 billion in the past five years alone. Their experience positions them as a formidable representative for investors in this case.

For those who believe they may qualify as lead plaintiffs or would like more information regarding their legal rights in this situation, they are encouraged to reach out to attorney J.C. Sanchez at Robbins Geller or complete the form available on the firm’s website for further assistance.

The content above is a summary. For more details, see the source article.